Intraoperative platelet and plasma improves survival in patients operated for a rAAA: a follow-up evaluation

P I Johansson, F Swiatek, L Jørgensen, L P Jensen, N H Secher


OBJECTIVES: Continued haemorrhage remains a significant contributor to mortality in massively transfused patients. We found that early administration of platelets and plasma reduced mortality from 54% to 36% in rAAA patients. The aim of the present evaluation was to evaluate whether reduced mortality in rAAA patients related to a pro-active transfusion therapy is maintained.

DESIGN: Single-centre observational study.

METHODS: Mortality of patients operated for rAAA 2006-07 was compared to that of patients operated 2004-05 (intervention group; n=50) and 2002-04 (control group, n=82).

RESULTS: 64 consecutive patients with rAAA received, similar to the intervention group, more platelets (5 and 4 vs. 0 units, P<0.05) and plasma (12 and 11 vs. 7 units, P<0.05) intraoperatively and had a higher platelet count (158 and 155 vs. 69 x 10(9)/L, P<0.0001) upon arrival at the intensive care unit and the 30-day mortality remained reduced (24% and 36% vs. 56%, P<0.01 and P=0.02, respectively) as compared to the control patients.

CONCLUSIONS: Early administration of platelets and plasma, together with red blood cells maintained reduced mortality in patients operated for rAAAin a 18 month period.

TidsskriftEuropean journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
Udgave nummer4
Sider (fra-til)397-400
Antal sider4
StatusUdgivet - okt. 2008
Udgivet eksterntJa


Dyk ned i forskningsemnerne om 'Intraoperative platelet and plasma improves survival in patients operated for a rAAA: a follow-up evaluation'. Sammen danner de et unikt fingeraftryk.